Acuitas, CureVac settle lawsuit over COVID-19 vaccine patent rights
Biotech company Acuitas Therapeutics and Germany-based CureVac have settled Acuitas’ lawsuit demanding credit for inventions related to COVID-19 vaccines, according to a filing on Thursday in Virginia federal court.